CMSB is a wholly-owned subsidiary of HARPS in 2017. CMSB was incorporated in 2004 and has been principally engaged in manufacturing and marketing of examination gloves. Over the years CMSB have expanded from a single manufacturing facility with total 6 production lines and an annual manufacturing capacity of 1.1 billion nitrile examination gloves in 2015 to 27 production lines with a total annual installed production capacity of 8 billion gloves in 2020. Central Medicare is targeted to increase to 34 production lines with an annual capacity of 11.6 billion by 2021.Our employees are our greatest asset when it comes to growth and success. We believe in sharing knowledge and experiences to achieve and deliver excellence at every stage of our production and development, in order to bring you the very best service.We always stay in line with our motto, "We work as a team, we stay as a team".
CMSB is a wholly-owned subsidiary of HARPS in 2017. CMSB was incorporated in 2004 and has been principally engaged in manufacturing and marketing of examination gloves. Over the years CMSB have expanded from a single manufacturing facility with total 6 production lines and an annual manufacturing capacity of 1.1 billion nitrile examination gloves in 2015 to 27 production lines with a total annual installed production capacity of 8 billion gloves in 2020. Central Medicare is targeted to increase to 34 production lines with an annual capacity of 11.6 billion by 2021.Our employees are our greatest asset when it comes to growth and success. We believe in sharing knowledge and experiences to achieve and deliver excellence at every stage of our production and development, in order to bring you the very best service.We always stay in line with our motto, "We work as a team, we stay as a team".
CMSB is a wholly-owned subsidiary of HARPS in 2017. CMSB was incorporated in 2004 and has been principally engaged in manufacturing and marketing of examination gloves. Over the years CMSB have expanded from a single manufacturing facility with total 6 production lines and an annual manufacturing capacity of 1.1 billion nitrile examination gloves in 2015 to 27 production lines with a total annual installed production capacity of 8 billion gloves in 2020. Central Medicare is targeted to increase to 34 production lines with an annual capacity of 11.6 billion by 2021.Our employees are our greatest asset when it comes to growth and success. We believe in sharing knowledge and experiences to achieve and deliver excellence at every stage of our production and development, in order to bring you the very best service.We always stay in line with our motto, "We work as a team, we stay as a team".